“With the increasing competitive pressure in the pharmaceutical industry, rising personnel and production costs and changes in the
regulatory framework, we need to manage the company’s development in the business model very precisely. We find that the automated forecasting environment for the P&L, balance sheet and cash flow statement from Corporate Planning gives us all the possibilities of driver-based business model analysis and enables management interventions.”
Christopher Budde, Senior Controller
